High prevalence of Pneumocystis jiroveci colonization among young HIV-infected patients

Sonia Gutiérrez1, Rubén Morilla, Juan A León

  • 1Instituto de Biomedicina de Sevilla, Hospitales Universitarios Virgen del Rocío/CSIC/Universidad de Sevilla, Clinical and Molecular Epidemiology Seville, Spain. anisoguri@hotmail.com

Insights

Pneumocystis jiroveci colonization is common in young HIV-infected patients. Further research is needed to determine if this colonization is a risk factor for developing Pneumocystis pneumonia (PCP).

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Background:

  • Pneumocystis colonization prevalence in pediatric HIV is understudied.
  • HIV infection impacts immune function, increasing susceptibility to opportunistic infections.
  • Pneumocystis jiroveci is an opportunistic pathogen causing Pneumocystis pneumonia (PCP).

Purpose of the Study:

  • To determine the prevalence of Pneumocystis jiroveci colonization in young HIV-infected patients.
  • To identify common Pneumocystis jiroveci genotypes in this population.
  • To assess the association between colonization and subsequent PCP development.

Main Methods:

  • A cross-sectional study of 20 young HIV-infected patients.
  • Oropharyngeal wash samples analyzed using nested polymerase chain reaction (PCR).
  • Patients followed for 50 weeks to monitor for PCP development.

Main Results:

  • Pneumocystis jiroveci colonization detected in 40% (8/20) of samples.
  • Genotype 85C/248C (genotype 1) was the most prevalent.
  • One colonized patient with advanced immunodepression developed PCP within 50 weeks.

Conclusions:

  • High prevalence of Pneumocystis jiroveci colonization observed in young HIV-infected patients.
  • Genotype 1 (85C/248C) is the predominant genotype in this cohort.
  • Further investigation is warranted to establish colonization as a risk factor for PCP in this population.
Abstract

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...